2021 American Transplant Congress
Impact of Transplant Center Volume on Utilization of and Outcomes Following Donation After Circulatory Death Liver Transplantation in the United States
*Purpose: Despite increased utilization of donation after circulatory death (DCD) grafts in the US, impact of center volume on DCD liver transplantation (LT) remains unclear.…2021 American Transplant Congress
Relationship of Functional Frailty and Radiographic Sarcopenia to Outcomes After Liver Transplant
Comprehensive Transplant Center, Northwestern University, Chicago, IL
*Purpose: Frailty and sarcopenia are associated with increased risk of hospitalization and mortality in end stage liver disease patients. Frailty can be measured clinically using…2021 American Transplant Congress
Molecular Assessment of Fibrosis and Steatohepatitis in the INTERLIVER Study
1Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, 2., ., AB, Canada
*Purpose: We previously reported a molecular system for assessing rejection in liver transplants and recently expanded this system to assess injury. Fibrosis is associated with…2021 American Transplant Congress
Peri-operative Liver Transplant Anesthesia Practice Patterns in the United States
*Purpose: Transplant anesthesiology is an evolving subspecialty and has not been the subject of an overall review of practice patterns in the United States since…2021 American Transplant Congress
Anonymous Live Liver Donor Perspectives on Anonymity in the Donation Process
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada
*Purpose: Anonymous living organ donation has recently become a more regular practice in select transplant programs, with donors coming forward voluntarily to give their organs…2021 American Transplant Congress
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation
Baylor University Medical Center, Dallas, TX
*Purpose: Hepatic artery thrombosis (HAT) is a severe complication in liver transplantation (OLTX). Re-OLTX for patients with HAT has been met with controversy due to…2021 American Transplant Congress
Implementation of an Alcohol Screening Program Identifies Active Pre-transplant Drinking and Allows Engagement in Chemical Dependency Treatment
*Purpose: Alcohol (ETOH) is an important cause of cirrhosis in the US today. Screening patients for ETOH use prior to LT is important to identify…2021 American Transplant Congress
Is Low Systemic Fibrinolytic Activity During the Anhepatic Phase Liver Transplant Surgery Associate with the Dreaded Post-Operative Complication of Hepatic Artery Thrombosis?
1University of Colorado, Aurora, CO, 2Childrens Hospital Colorado, Aurora, CO
*Purpose: Removal of the native liver during transplantation results in impaired clearance of clot degrading proteins and activation of fibrinolysis as appreciated by Starzl in…2021 American Transplant Congress
Liver Transplant Outcomes Using Nationally Allocated Grafts
*Purpose: There is national variation in acceptance criteria and utilization of livers across transplant centers. Data pertaining to outcomes of liver grafts declined by local…2021 American Transplant Congress
Artificial Neural Network Application for MELDNa Prediction
1University of Minnesota, Minneapolis, MN, 2Cleveland Clinic Foundation, Cleveland, OH
*Purpose: The adoption of MELDNa decreased 90-days mortality on patients waiting for liver transplant (LT); however, there are no tools available to predict MELDNa trajectories…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 180
- Next Page »